We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Alignment Healthcare (ALHC - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Alignment Healthcare is a member of our Medical group, which includes 999 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Alignment Healthcare is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ALHC's full-year earnings has moved 34.1% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, ALHC has returned 44.4% so far this year. Meanwhile, stocks in the Medical group have lost about 4.8% on average. This means that Alignment Healthcare is outperforming the sector as a whole this year.
BridgeBio Pharma (BBIO - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 22.8%.
In BridgeBio Pharma's case, the consensus EPS estimate for the current year increased 8% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Alignment Healthcare belongs to the Medical Services industry, a group that includes 58 individual stocks and currently sits at #52 in the Zacks Industry Rank. This group has lost an average of 1.9% so far this year, so ALHC is performing better in this area.
BridgeBio Pharma, however, belongs to the Medical - Generic Drugs industry. Currently, this 11-stock industry is ranked #198. The industry has moved -15.1% so far this year.
Going forward, investors interested in Medical stocks should continue to pay close attention to Alignment Healthcare and BridgeBio Pharma as they could maintain their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Alignment Healthcare (ALHC - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Alignment Healthcare is a member of our Medical group, which includes 999 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Alignment Healthcare is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ALHC's full-year earnings has moved 34.1% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, ALHC has returned 44.4% so far this year. Meanwhile, stocks in the Medical group have lost about 4.8% on average. This means that Alignment Healthcare is outperforming the sector as a whole this year.
BridgeBio Pharma (BBIO - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 22.8%.
In BridgeBio Pharma's case, the consensus EPS estimate for the current year increased 8% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Alignment Healthcare belongs to the Medical Services industry, a group that includes 58 individual stocks and currently sits at #52 in the Zacks Industry Rank. This group has lost an average of 1.9% so far this year, so ALHC is performing better in this area.
BridgeBio Pharma, however, belongs to the Medical - Generic Drugs industry. Currently, this 11-stock industry is ranked #198. The industry has moved -15.1% so far this year.
Going forward, investors interested in Medical stocks should continue to pay close attention to Alignment Healthcare and BridgeBio Pharma as they could maintain their solid performance.